← Browse by Condition
Medical Condition
intracranial artery stenosis
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4
ClinicalMetric tracks all active clinical trials for intracranial artery stenosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
NCT05692882
Recruiting
A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China
Enrollment
1,000 pts
Location
China
Sponsor
Sino Medical Sciences Technolo...
NCT06902740 Phase 4
Recruiting
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Enrollment
300 pts
Location
China
Sponsor
Peking Union Medical College H...
NCT07085299
Recruiting
Gut Microbiota and Prognostic Outcomes in Intracranial Arterial Stenosis Patients（GROW-ICAS）
Enrollment
500 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology